Hans-Peter Nestler

Title: Innovations of Hans-Peter Nestler

Introduction

Hans-Peter Nestler is an accomplished inventor based in Bridgewater, NJ (US). He has made significant contributions to the field of pharmacology, particularly through his innovative work on soluble epoxide hydrolase inhibitors. His research focuses on developing compounds that can have a profound impact on various health conditions.

Latest Patents

Hans-Peter Nestler holds a patent for "Isomannide derivatives as inhibitors of soluble epoxide hydrolase." This invention relates to compounds of the formula (I), wherein R1, R11, R12, and X have specific meanings as indicated in the claims. The compounds of formula I are recognized as valuable pharmacologically active compounds. They are highly potent and selective soluble epoxide hydrolase inhibitors, suitable for the therapy and prophylaxis of renal failure, diabetic nephropathy, type 2 diabetes mellitus, inflammation, and may also show beneficial effects in pain, dyslipidemia, and atherosclerosis. The invention further encompasses processes for the preparation of these compounds, their use as active ingredients in pharmaceuticals, and pharmaceutical preparations that include them.

Career Highlights

Hans-Peter Nestler is currently employed at Sanofi, a leading global healthcare company. His work at Sanofi allows him to collaborate with other talented professionals in the field, contributing to the advancement of medical science and patient care.

Collaborations

Some of his notable coworkers include Katrin Lorenz and Kristin Breitschopf. Their collaborative efforts enhance the innovative environment at Sanofi, fostering the development of groundbreaking pharmaceutical solutions.

Conclusion

Hans-Peter Nestler's contributions to the field of pharmacology through his patent on soluble epoxide hydrolase inhibitors exemplify the impact of innovative research on healthcare. His work continues to pave the way for advancements in the treatment of various medical conditions.